Differential effects of anti-β2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C

Blood

Volumn 91, Issue 6, 1998, Pages 1999-2004

  Galli, Monica ^a   Ruggeri, Luisa ^a   Barbui, Tiziano ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; BETA2 GLYCOPROTEIN 1; PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; THROMBOEMBOLISM; THROMBOSIS; VEIN THROMBOSIS;

EID: 0032521453     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.6.1999     Document Type: Article

References (24)

1. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87:4120, 1990
2. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda Vriesman PJC, Zwaal RFA, Bevers EM: Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335:1544, 1990
3. 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 68:297, 1992
4. Galli M, Bevers EM, Comfurius P, Barbui T, Zwaal RFA: Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles. Br J Haematol 83:466, 1993
5. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA: Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 66:629, 1991
6. 2-glycoprotein I-dependent antiphospholipid antibodies. Blood 86:617, 1995
7. Finazzi G, Brancaccio V, Moia M, Ciavarella N, Mazzucconi G, Schinco PC, Ruggeri M, Pogliani EM, Gamba G, Rossi E, Baudo F, Manotti C, D'Angelo A, Palareti G, De Stefano V, Berrettini M, Barbui T: Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the Italian Registry. Am J Med 100:53, 1996
8. Freyssinet JM, Cazenave JP: Lupus-like anticoagulants, modulation of the proein C pathway and thrombosis. Thromb Haemost 58:679, 1987
9. Marciniak E, Romond EH: Impaired catalytic function of activated protein C: A new in vitro manifestation of lupus anticoagulant. Blood 74:2426, 1989
10. Malia RG, Kitchen S, Greaves M, Preston FE: Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol 76:101, 1990
11. Smirnov MD, Triplett DA, Comp PC, Esmon NL, Esmon CT: On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. J Clin Invest 95:309, 1995
12. Martinuzzo M, Forastiero R, Adamczuk Y, Cerrato G, Carreras LO: Activated protein C resistance in patients with anti-beta 2 glycoprotein I antibodies. Blood Coagul Fibrinolysis 7:702, 1994
13. Bokarewa MI, Blomback N, Rosén S: A new variant of interaction between phospholipid antibodies and the protein C system. Blood Coagul Fibrinolysis 5:37, 1994
14. Brandt JT, Triplett DA, Alving B, Scharrer I: Criteria for the diagnosis of lupus anticoagulants: An update. Thromb Haemost 74: 1185, 1995
15. Norbis F, Barbui T, Galli M: Diluted Russell's viper venom time and colloidal silica clotting time for the identification of the phospholipid-dependent inhibitors of coagulation. Thromb Res 85:427, 1997
16. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN: Measurement of anticardiolipin antibodies by enzyme-linked immunosorbent assay: Standardization and quantitation of results. Clin Exp Immunol 62:738, 1985
17. Harris EN, Gharavi AE, Hughes GRV: The anti-cardiolipin assay, in Harris EN, Exner T, Hughes GRV, Asherson RA (eds): Phospholipid-binding Antibodies. Boca Raton, FL, CRC, 1991, p 175
18. Arvieux J, Roussel B, Jacob MC, Colomb MG: Measurement of anti-phospholipid antibodies by ELISA using β2-glycoprotein I as an antigen. J Immunol Methods 143:223, 1991
19. Polz E: Isolation of a specific lipid binding protein from human serum by affinity chromatography using heparin sepharose, in Peeters H (ed): Protides of Biological Fluids. Oxford, UK, Pergamom, 1979, p 817
20. Galli M, Beretta G, Daldossi M, Bevers EM, Barbui T: Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies Thromb Haemost 77:486, 1997
21. Sedmak JJ, Grossberg SE: A rapid, sensitive and versatile assay for protein using Coomassie brilliant blue G250. Ann Biochem 79:544, 1977
22. de Ronde H, Bertina RM: Laboratory diagnosis of aPC resistance: A critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 72:880, 1994
23. Matsuda J, Gotoh M, Gohchi K, Kawasugi K, Tsukamoto M, Saitoh N: Resistance to activated protein C activity of an anti-β2-glycoprotein I antibody in the presence of β2-glycoprotein I. Br J Haematol 90:204, 1995
24. Mori T, Takeya H, Nishioka J, Gabazza E, Suzuki K: β2-glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface. Thromb Haemost 75:49, 1996